Home › Funds › Burkehill Global Management, LP › MBX

Burkehill Global Management, LP position in MBX

MBX BIOSCIENCES INC · Health Care

Burkehill Global Management, LP reported holding 100,000 shares of MBX (MBX BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$5.9M, representing 0.26% of its reported portfolio and ranking #49 among its reported holdings. Burkehill Global Management, LP has disclosed MBX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)100.00K sh
Reported value held$5.86M
Portfolio Weight0.26%
First reportedQ3 2025
Last changeHold
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Burkehill Global Management, LP's MBX position evolved

Burkehill Global Management, LP first disclosed a stake in MBX in Q3 2025 at 100,000 shares (US$1.8M). The position peaked in Q3 2026 at 100,000 shares, worth US$5.9M. Across 5 filings, Burkehill Global Management, LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 100,000 shares valued at US$5.9M.

Quarter by quarter

QuarterSharesValueChange
Q3 2025 100.00K $1.75M New
Q4 2025 100.00K $3.15M Hold
Q1 2026 100.00K $2.98M Hold
Q2 2026 100.00K $5.52M Hold
Q3 2026 100.00K $5.86M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MBX and 13F data

MBX (MBX BIOSCIENCES INC) is a Health Care company. 57 other funds we track also report a position in MBX — the largest reported positions include Frazier Life Sciences Management, L.P. (US$389.9M), Paradigm Biocapital Advisors LP (US$221.2M), NEA Management Company, LLC (US$211.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MBX

All MBX fund holders →

FAQ

How long has Burkehill Global Management, LP held MBX?

Burkehill Global Management, LP has disclosed MBX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is Burkehill Global Management, LP's current position in MBX?

As of Q3 2026, Burkehill Global Management, LP holds 100.00K shares of MBX (MBX BIOSCIENCES INC), valued at $5.86M, representing 0.26% of its reported portfolio and ranking #49.

Has Burkehill Global Management, LP been buying or selling MBX?

In the latest 13F filing (Q3 2026), Burkehill Global Management, LP held unchanged its position in MBX. The position peaked in Q3 2026 at 100.00K shares.

Which other funds hold MBX?

Other major institutional holders of MBX include Frazier Life Sciences Management, L.P., Paradigm Biocapital Advisors LP, NEA Management Company, LLC, among 57 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.